EMAIL THIS PAGE TO A FRIEND

American journal of physiology. Lung cellular and molecular physiology

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.


PMID 25502501

Abstract

Pathological fibrosis is driven by a feedback loop in which the fibrotic extracellular matrix is both a cause and consequence of fibroblast activation. However, the molecular mechanisms underlying this process remain poorly understood. Here we identify yes-associated protein (YAP) (homolog of drosophila Yki) and transcriptional coactivator with PDZ-binding motif (TAZ) (also known as Wwtr1), transcriptional effectors of the Hippo pathway, as key matrix stiffness-regulated coordinators of fibroblast activation and matrix synthesis. YAP and TAZ are prominently expressed in fibrotic but not healthy lung tissue, with particularly pronounced nuclear expression of TAZ in spindle-shaped fibroblastic cells. In culture, both YAP and TAZ accumulate in the nuclei of fibroblasts grown on pathologically stiff matrices but not physiologically compliant matrices. Knockdown of YAP and TAZ together in vitro attenuates key fibroblast functions, including matrix synthesis, contraction, and proliferation, and does so exclusively on pathologically stiff matrices. Profibrotic effects of YAP and TAZ operate, in part, through their transcriptional target plasminogen activator inhibitor-1, which is regulated by matrix stiffness independent of transforming growth factor-β signaling. Immortalized fibroblasts conditionally expressing active YAP or TAZ mutant proteins overcome soft matrix limitations on growth and promote fibrosis when adoptively transferred to the murine lung, demonstrating the ability of fibroblast YAP/TAZ activation to drive a profibrotic response in vivo. Together, these results identify YAP and TAZ as mechanoactivated coordinators of the matrix-driven feedback loop that amplifies and sustains fibrosis.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

685720
3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole, 97%
C30H27N3
M6514
3-(Trimethoxysilyl)propyl methacrylate, ≥97%
C10H20O5Si
440159
3-(Trimethoxysilyl)propyl methacrylate, 98%
C10H20O5Si
32883
4-tert-Octylphenol monoethoxylate solution, 1 μg/mL in acetone, analytical standard
C16H26O2
32882
4-tert-Octylphenol monoethoxylate solution, 10 μg/mL in acetone, analytical standard
C16H26O2
01700
Acrylamide, purum, ≥98.0% (GC)
C3H5NO
01696
Acrylamide, for Northern and Southern blotting, powder blend
C3H5NO
08267
Acrylamide, certified reference material, TraceCERT®
C3H5NO
23701
Acrylamide, analytical standard
C3H5NO
01697
Acrylamide solution, 40% in H2O, for molecular biology
C3H5NO
HPA007415
Anti-WWTR1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
H8502
Dopamine hydrochloride
C8H11NO2 · HCl
PHR1090
Dopamine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
C8H11NO2 · HCl
D2960000
Dopamine hydrochloride, European Pharmacopoeia (EP) Reference Standard
C8H11NO2 · HCl
47673
Formaldehyde solution, tested according to Ph.Eur.
CH2O
76523
L-Glutamine, certified reference material, TraceCERT®
C5H10N2O3
PHR1125
L-Glutamine, Pharmaceutical Secondary Standard; Certified Reference Material
C5H10N2O3
146072
N,N′-Methylenebis(acrylamide), 99%
C7H10N2O2
M7279
N,N′-Methylenebisacrylamide, powder, for molecular biology, for electrophoresis, ≥99.5%
C7H10N2O2
M7256
N,N′-Methylenebisacrylamide, suitable for electrophoresis (after filtration or allowing insolubles to settle)
C7H10N2O2
M1533
N,N′-Methylenebisacrylamide solution, for electrophoresis, 2% in H2O
C7H10N2O2